Joint Formulary & PAD

Fondaparinux sodium - Acute coronary syndrome

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Subcutaneous injection (sc)
Associated Icons :
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Fondaparinux sodium
Indication :
Acute coronary syndrome
Group Name :
Keywords :
ST-elevation myocardial infarction, STEMI, non-ST elevation myocardial infarction, NSTEMI, unstable angina, ACS
Brand Names Include :
Important Information :
Unstable angina and NSTEMI. Caution - potential for latex reactions in allergic patients
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Fondaparinux sodium is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Acute coronary syndrome.

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.